Literature DB >> 1023955

Reactions to intravenous injections of diazepam.

H Siebke, B B Ellertsen, B Lind.   

Abstract

Local reactions during and after i.v. injection of two different formulations of diazepam were studied. Two-thirds of the patients felt pain during the injection. Verfied or probable thrombophlebitis occurred with increasing frequency following operation, indicating a late onset. One month after discharge, 29% of those who had received diazepam in glycoferol-alcohol-benzoic acid complained of tender injection sites, compared with only 10% of the patients who received diazepam in cremophor EL. The difference is significant, indicating an influence of the solvent system.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1023955     DOI: 10.1093/bja/48.12.1187

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  6 in total

1.  Pharmacokinetics of intravenous anaesthetics: implications for clinical use.

Authors:  M M Ghoneim; K Korttila
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

2.  Sequelae after the intravenous injection of three benzodiazepines--diazepam, lorazepam, and flunitrazepam.

Authors:  J E Hegarty; J W Dundee
Journal:  Br Med J       Date:  1977-11-26

3.  Reduction of venous complications of intravenous diazepam.

Authors:  A L Sisk
Journal:  Anesth Prog       Date:  1985 Nov-Dec

4.  Pharmacological methods and research issues in the management of the adult patient.

Authors:  J T Jastak
Journal:  Anesth Prog       Date:  1986 Jan-Feb

5.  A prospective randomised controlled trial of diazepam (valium) vs emulsified diazepam (diazemuls) as a premedication for upper gastrointestinal endoscopy.

Authors:  D Gleeson; J D Rose; P M Smith
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335

Review 6.  Adverse effects of intravenously administered drugs used in anaesthetic practice.

Authors:  R S Clarke
Journal:  Drugs       Date:  1981-07       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.